mafosfamide has been researched along with Leukemia L 1210 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farquhar, D; Wang, YQ | 1 |
| Bony, V; Jiang, R; Lopez, M | 1 |
| Hoser, G; Kawalec, M; Kawiak, J; Skórski, T | 1 |
| Kwon, CH; Moon, KY | 1 |
| Kawalec, M; Kawiak, J; Ratajczak, MZ; Skórski, T | 1 |
| Maki, PA; Sladek, NE | 1 |
| Kawalec, M; Kawiak, J; Skórski, T | 4 |
| Kohn, FR; Landkamer, GJ; Manthey, CL; Ramsay, NK; Sladek, NE | 1 |
| Schwieder, G; Wagner, T; Zink, M | 1 |
| Kawalec, M; Skórski, T | 2 |
14 other study(ies) available for mafosfamide and Leukemia L 1210
| Article | Year |
|---|---|
Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
Topics: Animals; Antineoplastic Agents; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Survival; Drug Screening Assays, Antitumor; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Phosphoramide Mustards; Prodrugs; Structure-Activity Relationship | 1991 |
Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Topics: Amifostine; Animals; Bone Marrow Purging; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Hematopoietic Stem Cells; In Vitro Techniques; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Transplantation, Autologous | 1994 |
Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclophosphamide; Drug Resistance; Female; Immunization; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tumor Cells, Cultured | 1993 |
N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cyclophosphamide; Leukemia L1210; Mice; Mice, Inbred BALB C; Prodrugs; Rats; Tumor Cells, Cultured | 1998 |
Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoiesis; Hematopoietic Stem Cells; Immune Tolerance; Immunity, Innate; Leukemia L1210; Leukemia, Experimental; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Whole-Body Irradiation | 1991 |
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Hematopoietic Stem Cells; Inactivation, Metabolic; Kinetics; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Phosphoramide Mustards; Procarbazine | 1991 |
Early induction of immune resistance against leukemia in mice after lethal irradiation followed by syngeneic bone marrow transplantation and injection of syngeneic leukocytes.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Transplantation; Cell Adhesion; Cyclophosphamide; Female; Immunity, Innate; Immunotherapy, Adoptive; Leukemia L1210; Leukemia, Experimental; Leukocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Time Factors; Transplantation, Isogeneic; Whole-Body Irradiation | 1991 |
Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Female; Immunotherapy, Adoptive; Leukemia L1210; Male; Mice; Mice, Inbred BALB C | 1990 |
Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice.
Topics: Animals; Antibodies; Antigens, Neoplasm; Antineoplastic Agents; Bone Marrow Transplantation; Complement System Proteins; Cyclophosphamide; Immunization; Immunization, Passive; In Vitro Techniques; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Plasmacytoma | 1990 |
Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Topics: Aldehyde Dehydrogenase; Animals; Colony-Forming Units Assay; Cyanamide; Cyclophosphamide; Disulfiram; Ditiocarb; Drug Resistance; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia L1210; Mice; NAD; Organophosphorus Compounds; Phosphinic Acids; Phosphoramide Mustards | 1987 |
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Topics: Animals; Cyclophosphamide; Cysteine; Drug Interactions; Female; Leukemia L1210; Mercaptoethanol; Mesna; Metabolic Clearance Rate; Mice; Platelet Count; Sulfhydryl Compounds | 1987 |
Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Immunotherapy; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Tumor Cells, Cultured | 1988 |
Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Immunization; Leukemia L1210; Mice; Whole-Body Irradiation | 1987 |
New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cells, Cultured; Cyclophosphamide; Female; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Vaccination | 1987 |